CSH Technology: ACQUITY CSH Columns Applications Notebook
|
|
- Jeremy Underwood
- 5 years ago
- Views:
Transcription
1 CS Technology: ACQUITY CS Columns Applications otebook
2 List of compounds analyzed using csh columns Lit Code Title Page WA Acetaminophen Impurities WA Acids, Bases, and eutrals WA Aromatic Acids WA Basic Drugs WA Beta Blockers WA Buproprion ydrochloride (Wellbutrin) in Extended Release Tablets 7 WA ozapine Impurities 8 WA Food Additives 9 WA Formic and Acetic Acid 0 WA8 Mirtazapine Impurities WA7 onsteroidal Anti-Inflammatory Drugs (SAIDS) WA9 rganic Acids WA8 Paroxetine Impurities WA9 Paroxetine Isomers WA0 Pharmaceutical Test Mix WA7 Statin Drugs 7 WA Sulfa Drugs 8 WA Tricyclic Antidepressants 9 WA0 Veterinary Drugs 0
3 ACQUITY CS WA Analysis of Acetaminophen Impurities Using ACQUITY CS Columns LC CDITIS ACQUITY CS Fluoro-Phenyl,. x 0 mm,.7 μm Part umber: 800 Mobile Phase A: 0.% acetic acid in Mobile Phase B: acetonitrile Gradien: Time Flow (min) (ml/min) %A %B Curve Initial Initial μl Column Temperature: 0 C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: 9/ /acetonitrile 9/ acetonitrile/ 70 nm 0 points/sec 0. sec ACQUITY UPLC System with -Aminophenol -itrophenol Acetaminophen -Chloroacetanilide Aminophenol ( mg/ml). Acetaminophen (0. mg/ml). -itrophenol ( mg/ml). -Chloroacetanilide ( mg/ml) min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
4 LC CDITIS Columns: ACQUITY CS C 8,. x 0 mm,.7 μm Part umber: 8009 ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Part umber: 8000 ACQUITY CS Fluoro-Phenyl,. x 0 mm,.7 μm Part umber: 800 Mobile Phase A: 0.% formic acid in (p ~.7) Mobile Phase B: Gradient Table: acetonitrile Time (min) Flow (ml/min) Analysis of Acids, Bases, and eutrals Using ACQUITY CS Columns %A %B Curve Imipramine S Amitriptyline ACQUITY CS WA Initial 0. 9 Initial Pyrenesulfonic acid Flavone μl (PL) /7 methanol/ C Column Temperature: 0 C Fenoprofen Weak eedle Wash: 9/ /acetonitrile Strong eedle Wash: 9/ acetonitrile/ nm 0 points/sec C Filter Time Constant: 0. sec ACQUITY UPLC System with column manager Diclofenac ctanophenone and detector ACQUITY CS C8 7. Imipramine (00 µg/ml). Amitriptyline (00 µg/ml). -Pyrenesulfonic acid (0 µg/ml) 0. ACQUITY CS Phenyl-exyl Flavone (0 µg/ml). Fenoprofen (00 µg/ml). Diclofenac (00 µg/ml) 7. ctanophenone (00 µg/ml) ACQUITY CS Fluoro-Phenyl min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
5 ACQUITY CS WA Analysis of Aromatic Acids Using ACQUITY CS Columns LC CDITIS ACQUITY CS C 8,. x 0 mm,.7 μm Part umber: 8009 Mobile Phase A: 0.% acetic acid in Mobile Phase B: acetonitrile Time Flow (min) (ml/min) %A %B Curve Sample Concentration: 0 µg/ml each Initial Initial μl Column Temperature: 0 C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: 9/ /acetonitrile 9/ acetonitrile/ 80 nm 0 points/sec 0. sec ACQUITY UPLC System with C Protocatechuic acid C -ydroxybenzoic acid C C Vanillic acid C C C C Syringic acid Salicylic acid,-dihydroxyphenylacetic acid (DPAC) C C,-Dichlorophenoxyacetic acid (Weed B Gon) 0.0. Protocatechuic acid.,-dihydroxyphenylacetic acid (DPAC) 0.. -ydroxybenzoic acid. Vanillic acid. Syringic acid Salicylic acid 7.,-Dichlorophenoxyacetic acid (Weed B Gon) min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
6 LC CDITIS Part umber: 8000 ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Mobile Phase A: 0 mm ammonium formate, p Mobile Phase B: acetonitrile μl Column Temperature: 0 C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: Time (min) 9/ /acetonitrile 9/ acetonitrile/ 0 nm 0 points/sec 0. sec ACQUITY UPLC System with ACQUITY UPLC PDA Flow (ml/min) %A %B Curve Initial 0. 9 Initial Analysis of Basic Drugs Using ACQUITY CS Columns C C C -aminopyrazine Quinine Labetalol C Verapamil C C S Pindolol Diltiazem Amitriptyline C ACQUITY CS WA aminopyrazine ( μg/ml). Pindolol (0 μg/ml) 0.. Quinine (0 μg/ml) Quinine impurity. Labetalol (0 μg/ml). Diltiazem impurity 7. Diltiazem ( μg/ml) Verapamil (0 μg/ml) 9. Amitriptyline ( μg/ml) min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
7 ACQUITY CS WA Analysis of Beta Blockers Using ACQUITY CS Columns LC CDITIS ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Part umber: 8000 Mobile Phase A: 0 mm ammonium formate, p Mobile Phase B: acetonitrile Time Flow (min) (ml/min) %A %B Curve Initial 0. 9 Initial μl Sample Concentration: 0 µg/ml each Column Temperature: 0 C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: 9/ /acetonitrile 9/ acetonitrile/ 80 nm 0 points/sec 0. sec ACQUITY UPLC System with C Atenolol Metoprolol Pindolol Labetalol xprenolol Propranolol Atenolol. Pindolol. Metoprolol. xprenolol. Labetalol Propranolol min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
8 LC CDITIS Part umber: 8009 Mobile Phase A: Mobile Phase B: Mobile Phase C: Analysis of Bupropion ydrochloride (Wellbutrin) in Extended Release TabletsUsing ACQUITY CS Columns ACQUITY CS C 8,. x 0 mm,.7 μm acetonitrile % formic acid in Time (min) Flow (ml/min) %A %B %C Curve Sample Preparation ProcedurE Ten extended release tablets (each containing 00 mg bupropion hydrochloride) were homogenized in 0 ml of 0/0 methanol/ to give 0 mg/ml of bupropion hydrochloride. The sample was then centrifuged at 000 rpm for 0 minutes. The supernatant was then diluted to 0.0 mg/ml in and filtered through a 0. µm PVDF syringe filter prior to injection. ACQUITY CS WA Initial Initial μl Sample Concentration: 0 µg/ml Bupropion Column Temperature: 0 C Wash Solvent: 0/0 /acetonitrile Purge Solvent: 0/0 /acetonitrile ACQUITY UPLC -ass with Compound. Bupropion (pk a = 7.9) Peak width (.%) =. seconds USP tailing factor = min 7 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
9 ACQUITY CS WA Analaysis of ozapine Impurities Using ACQUITY CS Columns LC CDITIS ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Part umber: 8000 Mobile Phase A: Mobile Phase B: acetonitrile Mobile Phase C: % formic acid in Time Flow (min) (ml/min) %A %B %C Curve μl 80/0 methanol/ Sample Concentration: 00 µg/ml (impurities present at ~0.%) Column Temperature: 0 C Wash Solvent: Purge Solvent: Initial Initial /0 /acetonitrile 0/0 /acetonitrile ACQUITY UPLC -ass with and SQD MS Conditions Capillary:.0 kv (ES + ) Cone: Extractor: 0 V V Desolvation Temperature: 0 C Source Temperature: 0 C Desolvation Gas: Scan Range: Scan Rate: 8-Chloro--(piperazin--yl)-dibenzo[b,e][,]-diazepine 800 L/hr 00 to 0 m/z 000 Da/sec ozapine -[-[(-Amino--chlorophenyl)amino] benzoyl]--methylpiperazine,'-(piperazine-,-diyl) bis(8-chloro--dibenzo [b,e][,]diazepine) 8-Chloro-,0-dihydro- -dibenzo[b,e][,] diazepin--one Intensity Intensity Intensity Intensity UV nm - 0 min.0 x 0.0 x x 0.0 x x 0.0 x x 0.0 x 0 Extracted Ion Chromatogram at m/z. Extracted Ion Chromatogram at m/z. Extracted Ion Chromatogram at m/z 9. Extracted Ion Chromatogram at m/z.0. 8-Chloro--(piperazin--yl)--dibenzo[b,e][,]-diazepine. ozapine. -[-[(-Amino--chlorophenyl)amino]benzoyl]- -methylpiperazine.,'-(piperazine-,-diyl)bis(8-chloro--dibenzo[b,e] [,]diazepine). 8-Chloro-,0-dihydro--dibenzo[b,e][,]diazepin--one 0 0 min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation. 8
10 LC CDITIS Part umber: 800 Mobile Phase A: Mobile Phase B: ACQUITY CS Fluoro-Phenyl,. x 0 mm,.7 μm 0.% phosphoric acid in acetonitrile Initial μl Column Temperature: 0 C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: Time (min) 9/ /acetonitrile 9/ acetonitrile/ 0 nm 0 points/sec 0. sec Flow (ml/min) ACQUITY UPLC System with %A %B Curve Analysis of Food Additives Using ACQUITY CS Columns p-ydroxybenzoic acid Dehydroacetic acid S Saccharin Sorbic acid C Methyl paraben ACQUITY CS WA p-ydroxybenzoic acid (0 µg/ml). Sorbic acid (0 µg/ml). Dehydroacetic acid (00 µg/ml). Methyl paraben ( µg/ml). Saccharin (00 µg/ml) min 9 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
11 ACQUITY CS WA Analysis of Formic and Acetic Acids Using ACQUITY CS Columns LC CDITIS ACQUITY CS C 8,. x 00 mm,.7 μm Part umber: Isocratic Mobile Phase: 0.% phosphoric acid in Flow Rate: 0. ml/min μl Sample Concentration: 0.0% Column Temperature: 0 C Weak eedle Wash: 9/ /acetonitrile Strong eedle Wash: 9/ acetonitrile/ 0 nm 0 points/sec Filter Time Constant: 0. sec ACQUITY UPLC System with Formic acid Acetic acid Formic acid. Acetic acid min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation. 0
12 LC CDITIS ACQUITY CS C 8,. x 0 mm,.7 μm Part umber: 8009 Mobile Phase A: 0.% ammonium hydroxide in Mobile Phase B: acetonitrile Time Flow (min) (ml/min) %A %B Curve μl Sample Concentration: mg/ml of mirtazapine USP resolution standard Column Temperature C Weak eedle Wash: Strong eedle Wash: Filter Time Constant: Initial Initial /0 acetonitrile/ 0/0 /acetonitrile 0/0 acetonitrile/ 90 nm 0 points/sec 0. sec ACQUITY UPLC System with Analysis of Mirtazapine Impurities Using ACQUITY CS Columns Mirtazapine Impurity A Mirtazapine Impurity D Mirtazapine Impurity B Mirtazapine Impurity C Mirtazapine Impurity E ACQUITY CS WA8 Mirtazapine Impurity F Mirtazapine Mirtazapine Impurity A (0.%). Mirtazapine Impurity B (0.0%). Mirtazapine Impurity C or F (0.09%). Mirtazapine Impurity D (0.%). Mirtazapine (98.8%). Unknown impurity (0.08%) 7. Mirtazapine Impurity E (0.%) 8. Mirtazapine Impurity C or F (0.%) min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
13 ACQUITY CS WA7 Analysis of onsteroidal Anti-Inflammatory Drugs (SAIDS) Using ACQUITY CS Columns LC CDITIS ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Part umber: 8000 Mobile Phase A: Mobile Phase B: acetonitrile Mobile Phase C: % formic acid in Time Flow (min) (ml/min) %A %B %C Curve Tolmetin C Initial Initial Fenoprofen C Ibuprofen μl Column Temperature: 0 C Wash Solvent: Purge Solvent: 0/0 /acetonitrile 0/0 /acetonitrile 70 nm 0 points/sec C aproxen C C Diclofenac Filter Time Constant: 0. sec ACQUITY UPLC -ass System with C C Indomethacin 0.. Tolmetin (0 µg/ml) 0.. aproxen (0 µg/ml). Fenoprofen (0 µg/ml) 0.. Ibuprofen (00 µg/ml) 0.0. Indomethacin (0 µg/ml). Diclofenac (0 µg/ml) min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
14 LC CDITIS ACQUITY CS C 8,. x 0 mm,.7 μm Part umber: Mobile Phase: 0.% phosphoric acid in Isocratic Flow Rate: 0. ml/min to μl Sample Concentration: µg/ml (0 µg/ml for lactic acid) (0 µg/ml for lactic acid) Column Temperature: C Weak eedle Wash: 9/ /acetonitrile Strong eedle Wash: 9/ acetonitrile/ 0 nm 0 points/sec Filter Time Constant: 0. sec ACQUITY UPLC System with Sample Preparation Procedure: Samples were filtered through a 0. μm PTFE syringe filter and injected directly. Analysis of rganic Acids Using ACQUITY CS Columns DL-Tartaric acid Lactic Acid Succinic Acid L-Malic acid Acetic Acid C C C Citric Acid ACQUITY CS WA Vitamin-fortified (grape flavor). DL-Tartaric acid. L-Malic acid. Lactic Acid. Acetic Acid. Succinic Acid. Citric Acid Lemon-lime sports drink Standard mix min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
15 ACQUITY CS WA8 Analysis of Paroxetine Impurities Using ACQUITY CS Columns LC CDITIS ACQUITY CS Fluoro-Phenyl,. x 00 mm,.7 μm Part umber: 800 Mobile Phase A: Mobile Phase B: methanol Mobile Phase C: % acetic acid in Time Flow (min) (ml/min) %A %B %C Curve Pre-Injector volume: 00 µl μl Sample Concentration: paroxetine at 0. mg/ml; impurities at Column Temperature: 0 C Wash Solvent: Purge solvent: Filter Time Constant: Initial Initial mg/ml each 0/0 /acetonitrile 0/0 /acetonitrile 9 nm 0 points/sec 0. sec ACQUITY UPLC -ass System with F Paroxetine trans--phenyl--[[,-(methylenedioxy) phenoxy]methyl]piperidine F F cis-paroxetine (S-trans)--Methyl--[(,-benzodioxol--yloxy) methyl]--(-fluorophenyl)piperidine. trans--phenyl--[(,-methylenedioxy) phenoxymethyl]-piperidine hydrochloride. cis-paroxetine. Paroxetine hydrochloride. (S-trans)--Methyl--[(,-benzodioxol-- yloxy)methyl]--(-fluorophenyl)piperidine min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
16 LC CDITIS Part umber: 800 Mobile Phase A: Mobile Phase B: Mobile Phase C: ACQUITY CS Fluoro-Phenyl,. x 00 mm,.7 μm methanol Pre-Injector volume: 00 µl % acetic acid in μl Sample Concentration: µg/ml each Column Temperature: 0 C Wash Solvent: Purge Solvent: Time (min) Flow (ml/min) 0/0 /acetonitrile 0/0 /acetonitrile ACQUITY UPLC -ass System with SQD %A %B %C Curve Initial Initial Analysis of Paroxetine Isomers Using ACQUITY CS Columns MS Conditions Capillary:.0 kv (ES + ) Cone: 0 V Extractor: V Desolvation Temperature: 0 C Source Temperature: 0 C Desolvation Gas: 800 L/hr Scan Range: 00 to 00 m/z Scan Rate: 000 Da/sec F cis-paroxetine F (+)-trans-paroxetine ACQUITY CS CS Columns WA9 8x0 7x0. cis-paroxetine. (+)-trans-paroxetine x0 x0 Intensity x0 x0 x0 x0 0 0 Extracted ion chromatogram at m/z min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
17 ACQUITY CS WA0 Analysis of Pharmaceutical Test Mix on ACQUITY CS Columns LC CDITIS Columns: ACQUITY CS C 8,. x 0 mm,.7 μm Mobile Phase A: Mobile Phase B: Mobile Phase C: Part umber: 8009 ACQUITY CS Phenyl-exyl,. x 0 mm,.7 μm Part umber: 8000 ACQUITY CS Fluoro-Phenyl,. x 0 mm,.7 μm Part umber: 800 acetonitrile % formic acid in Time (min) μl Flow (ml/min) %A %B %C Curve Initial Initial F Triamcinolone -Amino-7-chloro--oxo- -[]benzopyrano[,-b] pyridine--carbonitrile 8-Bromoguanosine Acetanilide Br ydrocortisone -Aminofluoranthene Column Temperature: 0 C Wash Solvent: Purge Solvent: 0/0 /acetonitrile 0/0 /acetonitrile nm Perylene Filter Time Constant: 0 points/sec 0. sec ACQUITY UPLC -ass System with α-methyl-7αhydroxyprogesterone Br -Bromofluorene aphtho[,-a]pyrene ACQUITY CS C Bromoguanosine (. µg/ml). Acetanilide (.7 µg/ml) ACQUITY CS Phenyl-exyl Triamcinolone (. µg/ml). ydrocortisone (. µg/ml). -Amino-7-chloro--oxo--[]benzopyrano[,-b]pyridine--carbonitrile (. µg/ml). -Aminofluoranthene (. µg/ml) 7. α-methyl-7α-hydroxyprogesterone ( µg/ml) ACQUITY CS Fluoro-Phenyl Bromofluorene ( µg/ml) 9. Perylene (. µg/ml) 0. aphtho[,-a]pyrene (. µg/ml) 0 min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
18 LC CDITIS Part umber: 800 Mobile Phase A: Mobile Phase B: ACQUITY CS Fluoro-Phenyl,. x 0 mm,.7 μm 0.% formic acid in acetonitrile Time (min) Flow (ml/min) %A %B Curve Analysis of Statin Drugs Using ACQUTY CS Columns Structures a+ C ACQUITY CS CS Columns WA7 Initial 0. 9 Initial Pravastatin sodium C μl F Sample Concentration: 0 µg/ml each Column Temperature: 0 C 80/0 methanol/ Atorvastatin Weak eedle Wash: 9/ /acetonitrile Strong eedle Wash: 9/ acetonitrile/ 8 nm 0 points/sec Lovastatin Filter Time Constant: 0. sec ACQUITY UPLC System with Simvastatin 0.. Pravastatin sodium (Pravachol). Atorvastatin (Lipitor) 0.. Lovastatin (Mevacor). Simvastatin (Zocor) min 7 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
19 ACQUITY CS WA Analysis of Sulfa Drugs Using ACQUITY CS Columns LC CDITIS ACQUITY CS Fluoro-Phenyl,. x 00 mm,.7 μm Part umber: 800 Mobile Phase A: 0.% acetic acid in Mobile Phase B: acetonitrile Time Flow (min) (ml/min) %A %B Curve S Sulfanilamide S Sulfathiazole S Initial 0. 9 Initial μl S Sulfamerazine S Sulfamethazine Sample Concentration: 0 µg/ml each Column Temperature: 0 C Weak eedle Wash: 9/ /acetonitrile S S C S S Strong eedle Wash: 9/ acetonitrile/ nm Sulfamethizole Succinylsulfathiazole Filter Time Constant: 0 points/sec 0. sec ACQUITY UPLC System with S S Sulfamethoxazole Sulfasoxazole 0.0. Sulfanilamide. Sulfathiazole 0.. Sulfamerazine. Sulfamethazine Sulfamethizole. Succinylsulfathiazole 7. Sulfamethoxazole 8. Sulfasoxazole min 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation. 8
20 LC CDITIS Part umber: 8009 Mobile Phase A: Mobile Phase B: Mobile Phase C: ACQUITY CS C 8,. x 0 mm,.7 μm acetonitrile % formic acid in μl Sample Concentration: µg/ml each Column Temperature: 0 C Wash Solvent: Purge Solvent: Filter Time Constant: Time (min) 0/0 /acetonitrile 0/0 /acetonitrile nm 0 points/sec 0. sec Flow (ml/min) ACQUITY UPLC -ass System with and SQD Analysis of Tricyclic Antidepressants Using ACQUITY CS Columns %A %B %C Curve Initial Initial MS Conditions Capillary:.0 kv (ES + ) Cone: 0 V Extractor: V Desolvation Temperature: 0 C Source Temperature: 0 C Desolvation Gas: 800 L/hr Scan Range: 00 to 00 m/z Scan Rate: 000 Da/sec Doxepin Desipramine ACQUITY CS CS Columns WA Imipramine ortriptyline Doxepin. Desipramine. Imipramine. ortriptyline Amitriptyline UV min. Amitriptyline. Trimipramine.0x0 7 Intensity.0x0 7.0x0 7 Trimipramine.0x0 7 MS min 9 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation.
21 ACQUITY CS WA0 Analysis of Veterinary Drugs Using ACQUITY CS Columns LC CDITIS Columns: ACQUITY CS C 8,. x 00 mm,.7 μm Part umber: Mobile Phase A: Mobile Phase B: acetonitrile Mobile Phase C:.0% formic acid in (p ~.7) μl 0/90 methanol/ Column Temperature: 0 C Wash: % formic acid in ACQUITY UPLC -ass with TQD (MassLynx v..) TQD Conditions Capillary:.00 kv Extractor:.00 V RF: 0.0 V Source Temperature: 0 C Desolvation Temperature: 0 C Cone Gas Flow: 0 L/r Desolvation Gas Flow: 800 L/r Collision Gas Flow: Time (min) Flow (ml/min) 0.0 ml/min %A %B %C Curve Initial Initial Compound MRM transition (m/z) Cone (V) CID (ev) Ciprofloxacin.00> >. 0 Enrofloxacin 0.0>.8 0.0>.9 Erythromycin 7.8> >7.9 0 xacillin 0.0>0. 0.0>. xytetracycline.0>..0>.7 0 Penicillin-G.7> >7.0 0 Sulfamerazine.8> >. 0 Sulfamethazine 79.00> >. 0.0>0. Tetracycline.0> % F 9 Ciprofloxacin xytetracycline S Sulfamerazine S 7 8 Sulfamethazine min F Enrofloxacin S xacillin. Ciprofloxacin ( µg/ml). Enrofloxacin ( µg/ml). Erythromycin ( µg/ml). xacillin ( µg/ml). xytetracycline ( µg/ml). Penicillin G ( µg/ml) 7. Sulfamerazine ( µg/ml) 8. Sulfamethazine (0. µg/ml) 9. Tetracycline ( µg/ml) C S Penicillin G C Erythromycin C Tetracycline 00 Waters Corporation. Waters, The Science of What s Possible, ACQUITY CS and ACQUITY UPLC are trademarks of Waters Corporation. 0
22 ACQUITY CS TES
23 ACQUITY CS TES
24 ACQUITY CS TES
25 Sales ffices Austria and European Export (Central South Eastern Europe, CIS and Middle East) Australia Belgium Brazil Canada x0 China CIS/Russia / Czech Republic Denmark Finland France Germany ong Kong The etherlands orway Poland Puerto Rico Singapore Spain Sweden 8 00 Switzerland Taiwan United Kingdom All other countries: Waters Corporation U.S.A ungary 0 08 India and India Subcontinent Ireland 8 00 Italy Japan Korea Mexico 7 00 Waters Corporation. Waters, CS, ACQUITY UPLC, ACQUITY CS, MassLynx and The Science of What s Possible are trademarks of Waters Corporation. June E KK-PDF
viridis Columns Bringing a New Dimension to SFC Combining state-of-the-art media manufacturing with industry leading column technology, Viridis
[ viridis columns ] viridis Columns Bringing a New Dimension to SFC Combining state-of-the-art media manufacturing with industry leading column technology, Viridis Supercritical Fluid Chromatography (SFC)
More informationANALYSIS OF BASIC COMPOUNDS
COMPARISON OF Fully AND Superficially POROUS PARTICLE COLUMNS FOR THE ANALYSIS OF BASIC COMPOUNDS Kenneth J. Fountain, Jane Xu, Zhe Yin, Pamela C. Iraneta, Diane M. Diehl Waters Corporation GOAL Compare
More information[ Care and Use Manual ]
Oasis HLB DISKS I. Introduction Oasis HLB is a Hydrophilic-Lipophilic-Balanced, water-wettable, reversed-phase sorbent for all your SPE needs. It is made from a specific ratio of two monomers, the hydrophilic
More informationPut the. C18 aside. and take a look... Reasons. to try the. NEW Gemini C6-Phenyl
Put the C18 aside and take a look... 6 Reasons to try the EW Gemini Reason #6 ALTERATE SELECTIVITY to your C18 Column Adding to your method development options, Gemini offers additional polar and aromatic
More informationDEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR
DEMONSTRATING SUPERIOR LINEARITY: THE ACQUITY UPLC PHOTODIODE ARRAY DETECTOR Tanya Jenkins Waters Corporation, Milford, MA, USA INTRODUCTION ACQUITY UPLC PDA LINEARITY There are two characteristics that
More informationDetermination of Pharmaceuticals in Environmental Samples
Determination of Pharmaceuticals in Environmental Samples BACKGROUND The full effects of pharmaceutical substances in the environment are largely unknown however the risk is significant enough that many
More informationultimate efficiency unleashed [ Cortecs 1.6 µm columns ]
ultimate efficiency unleashed [ Cortecs columns ] [ CORTECS UPLC COLUMNS ] A SUB--µm SOLID-CORE PARTICLE COLUMN THAT LIVES UP TO ITS POTENTIAL. C 8 + C 8 HILIC SOLID-CORE PARTICLE COLUMNS THAT DELIVER
More informationSetting the Standard for ph Method Development
U.S. Patent o. 7, 56, 67 Setting the Standard for ph Method Development ugged reversed phase HPLC columns that offer extended lifetime at extreme ph conditions and excellent stability for reproducible,
More informationThe Standard for ph Method Development
The Standard for ph Method Development High Efficiency Excellent Lifetime ph Stable - www.phenomenex.com/gemini U.S. Patent No.,, Setting the Standard for ph Method Development Gemini columns are rugged
More informationDetermination of Verapamil Hydrochloride Purity Using the Acclaim PA Column
Application Note 95 Determination of Hydrochloride Purity Using the Acclaim PA Column INTRODUCTION -based medications are prescribed for several heart and blood pressure indications. The fastacting formulations
More informationApplicationNOTE ULTRA TRACE ANALYSIS OF DIOXINS AND FURANS IN HUMAN ADIPOSE TISSUE USING SFE-LC EXTRACTION/CLEANUP AND THE WATERS AUTOSPEC ULTIMA NT
Introduction Legislative limits for dioxins and furans are ever decreasing 1, providing a greater challenge for the dioxin analyst. The extraction and clean-up processes used by the analyst can be imperative
More information1.7µm Fortis C18 UHPLC Columns
Strength in Technology.7µm Fortis C8 Columns Ultra High Pressure Chromatography Increase Efficiency Increase Speed Improve Resolution Greater Sensitivity Wider Linear flow rate range .7µm Columns - 8m/g
More informationmau 200 ph min
mau ph - 6 8 TAKE A LOOK INSIDE TWIN Technology TWIN (Two-In-One ) Technology is what gives Gei its superior performance edge. During the final stage of silica manufacturing, a unique silica-organic layer
More informationSemi-Targeted Screening of Pharmaceutically- Related Contaminants in the Thames Tideway using LC-HRMS
Semi-Targeted Screening of Pharmaceutically- Related Contaminants in the Thames Tideway using LC-HRMS Kelly Munro, 1 Anthony Edge, 2 Claudia Martins, 3 David Cowan 4 and Leon Barron 1 1 Analytical & Environmental
More informationA Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance
A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance Michael D. Jones, Marian Twohig, Karen Haas, and Robert S. Plumb Waters Corporation,
More informationSimultaneous Determination of Pharmaceutical Peptides and Acetate Counterions by HPLC Using a Mixed-Mode Weak Anion-Exchange Column
Simultaneous Determination of Pharmaceutical Peptides and Acetate Counterions by PLC Deanna C. urum, Brian M. De Borba, and Jeffrey S. Rohrer Dionex Corporation, Sunnyvale, CA, USA ITRDUCTI Peptides perform
More informationGemini. Second-Generation TWIN-NX Technology. TWIN (Two-In-One) Technology. U.S. Patent No. 7, 563, 367 Setting the Standard for ph Method Development
U.S. Patent o. 7, 5, 7 Setting the Standard for ph Method Development ugged reversed phase HPLC columns that offer extended lifetime at extreme ph conditions and excellent stability for reproducible, high
More informationSetting the Standard for ph Method Development
U.S. Patent o. 7, 5, 7 Setting the Standard for ph Method Development ugged reversed phase HPLC columns that offer extended lifetime at extreme ph conditions and excellent stability for reproducible, high
More informationAPPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEY WORDS. Simultaneous high-throughput screening of melamine (MEL) and cyanuric acid (CYA).
A Rapid and Sensitive Method for the Simultaneous Determination of and Cyanuric Acid in Infant Formulas, Adult utritional Products, and Protein Powders APPLICATIO BEEFITS Simultaneous high-throughput screening
More information[ OSTRO PASS-THROUGH SAMPLE PREPARATION PRODUCT ] The Simpler Way to Cleaner Samples
[ OSTRO PASS-THROUGH SAMPLE PREPARATION PRODUCT ] The Simpler Way to Cleaner Samples SIMPLE EASY EFFICIENT DEPENDABLE 2 waters.com/ostro 3 SIMPLE The Ostro Pass-Through Sample Preparation Product provides
More informationRapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS
Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS Application Note Drug Discovery Authors Srividya Kailasam Agilent
More informationSimultaneous, Fast Analysis of Melamine and Analogues in Pharmaceutical Components Using Q Exactive - Benchtop Orbitrap LC-MS/MS
Simultaneous, Fast Analysis of Melamine and Analogues in Pharmaceutical Components Using Q Exactive - Benchtop Orbitrap LC-MS/MS Kate Comstock, Tim Stratton, Hongxia (Jessica) Wang, and Yingying Huang
More informationsurpass all possibilities [ Cortecs 2.7 µm columns ]
surpass all possibilities [ Cortecs.7 µm columns ] [ CORTECS.7 µm COLUMNS ] A SOLID-CORE PARTICLE COLUMN THAT LIVES UP TO ITS POTENTIAL. C 8 + C 8 HILIC.7 μm SOLID-CORE PARTICLE COLUMNS FOR HPLC AND UHPLC
More informationApplicationNOTE Abstract
Abstract It has long been known that a range of non-native, stable, saturated hydrocarbon biomarkers present in crude oil extracts could be used to identify the original facie from which the oil was formed.
More informationIN QUALITATIVE ANALYSIS,
IN QUALITATIVE ANALYSIS, YOU VE ALWAYS HAD TO CHOOSE BETWEEN ACCURACY AND THROUGHPUT. NOW THERE S NO REASON TO ever have to. WATERS QUALITATIVE ANALYSIS solutions Waters ACQUITY UPLC System with the Waters
More informationMultiple Fragmentation Methods for Small Molecule Characterization on a Dual Pressure Linear Ion Trap Orbitrap Hybrid Mass Spectrometer
Application ote: 54 Multiple Fragmentation Methods for Small Molecule Characterization on a Dual Pressure Linear Ion Trap rbitrap Hybrid Mass Spectrometer Kate Comstock, Yingying Huang; Thermo Fisher Scientific,
More informationAnalgesics / Cough 1 & Cold Medicine Ingredients
Analgesics / Cough & Cold Medicine Ingredients mau H. paracetamol H CH H H. -aobenzoic acid H H H C CH. -hydroxybenzoic acid 7 CH H CH. caffeine 8 9 H. -acetamidophenol 0 H H. -hydroxybenzoic acid H C8-AR
More informationA Unique, New, Multipurpose Sorbent Engineered for Reversed-Phase SPE
Poster #151 ISC '96 21st International Symposium on Chromatography, Stuttgart, September 15th-20th, 1996 1 A Unique, ew, Multipurpose Sorbent Engineered for Reversed-Phase SPE Authors 2 McDonald, P.D.*,
More informationAPPLICATIONS TN HPLC Conditions. Lux Cellulose-1 Cellulose tris(3,5-dimethylphenylcarbamate)
T-147 APPLICATIS Alternative Selectivity of Chiral Stationary Phases Based on Cellulose tris(3-chloro-4-methylphenylcarbamate) and Cellulose tris(3,5-dimethylphenylcarbamate) Liming Peng, Tivadar Farkas
More information4.1 MATERIALS 4.2 EQUIPMENTS
4.1 MATERIALS 1. Aceclofenac Moraceae Pharma Ltd., Uttarakhand, India 2. Diclofenac Arti Drugs Ltd., Mumbai, India 3. Paracetamol Moraceae Pharma Ltd., Uttarakhand, India 4. Para-aminophenol Hema Pharmaceuticals
More informationYun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION
Quantitation by High Resolution Mass Spectrometry: Using Target Enhancement and Tof-MRM to Achieve Femtogram-level On-column Sensitivity for Quantitation of Drugs in Human Plasma Yun W. Alelyunas, Mark
More informationHPLC COLUMNS VaRian, inc. Pursuit XRs EXtRa REsolution. Ma XiMuM lifetime. ultimate PERfoRMancE.
HPLC COLUMNS VARIAN, INC. XRs Pursuit E X tr a Resolution. Ma ximum Life time. Ultimate Performance. The new standard in HPLC Designed to deliver ultimate performance in the most demanding laboratories,
More informationAPPLICATIONS TN Lux Cellulose-2 or -4 Cellulose tris (3-chloro-4-methylphenylcarbamate) or (4-chloro-3-methylphenylcarbamate)
T-1079 APPLICATI Method Development for Reversed Phase Chiral LC/M/M Analysis of tereoisomeric Pharmaceutical Compounds with Polysaccharide-based tationary Phases Philip J. Koerner, Kari Carlson, Liming
More informationSeparation of Structurally Similar Steroids on HALO C18 and PFP
Application Note: 047-STR Separation of Structurally Similar Steroids on HALO C8 and PFP, 4 G009 HALO C8 HALO PFP 4. Prednisone. Cortisone. Prednisolone 4. Hydrocortisone 0 4 5 6 7 Columns: 4.6 x 00 mm,
More informationZirconia-Based Phases as a Powerful Complement to Silica-Based Phases for LC and LC-MS under Non-extreme Mobile Phase Conditions
Zirconia-Based Phases as a Powerful Complement to Silica-Based Phases for LC and LC-MS under on-extreme Mobile Phase Conditions Richard A. Henry, Shawn R. Wyatt, Carmen T. Santasania and David S. Bell
More informationDissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.
Atorvastatin Calcium Tablets Type of Posting Posting Date 25 Jan 2019 Official Date 01 Feb 2019 Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance In accordance with the Rules
More informationThe Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity
The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity Janet Hammond Waters Corporation, Wilmslow, UK APPLICATION BENEFITS High
More informationDeveloping a fast, generic method for rapid resolution LC with quadrupole MS detection. Application Note
Developing a fast, generic method for rapid resolution LC with quadrupole MS detection Combining the Agilent 6140 quadrupole MS and multimode source with the Agilent 1200 Series Rapid Resolution LC system
More informationKey Words Q Exactive Focus, Orbitrap, veterinary drugs, small molecule HRAM quantitation, small molecule HRAM screening, UHPLC, vdia
Variable Data-Independent Acquisition (vdia) Delivers High Selectivity and Sensitivity in Combined Targeted and Untargeted Analyses for Small Molecules Olaf Scheibner 1, Markus Kellmann 1, Charles Yang
More informationThe Analysis of Organic Acids in Foods and Beverages Using Reversed Phase HPLC
The Analysis of rganic Acids in Foods and Beverages Using Reversed Phase HPLC Rebecca E. Wittrig & Terrence S. Reid Restek Corporation Benner Circle, Bellefonte, PA 683 USA Restek Corporation www.restekcorp
More informationcolumns Acclaim Mixed-Mode WCX-1 for Separating Basic Molecules
columns Acclaim Mixed-Mode WCX- for Separating Basic Molecules The Acclaim Mixed-Mode WCX- is a novel, high-efficiency, silica-based column specially designed for separating various basic analytes. This
More informationFORENSIC TOXICOLOGY SCREENING APPLICATION SOLUTION
FORENSIC TOXICOLOGY SCREENING APPLICATION SOLUTION A purpose-built collection of the best-inclass components for forensic toxicology Whether you re challenged to present reliable and secure forensic sample
More informationDetermination of the Composition of Natural Products by HPLC with Charged Aerosol Detection. Introduction. Black Cohosh. Corona Detector Parameters
Determination of the Composition of Natural Products by HPLC with Charged Aerosol Detection Ian Acworth, Bruce Bailey, Paul Gamache, and John Waraska Thermo Fisher Scientific, Chelmsford, MA, USA Introduction
More informationA Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone
A Quality by Design (QbD) Based Method Development for the Determination of Impurities in a Peroxide Degraded Sample of Ziprasidone Mia Summers and Kenneth J. Fountain Waters Corporation, 34 Maple St.,
More informationLC-MS/MS Method for the Determination of Diclofenac in Human Plasma
LC-MS/MS Method for the Determination of Diclofenac in Human Plasma J. Jones, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 20569 Key Words SPE, SOLA, Accucore RP-MS, diclofenac, Core
More informationUltrasensitive EPA Method 1694 with the Agilent 6460 LC/MS/MS with Jet Stream Technology for Pharmaceuticals and Personal Care Products in Water
Ultrasensitive EPA Method 1694 with the Agilent 6460 LC/MS/MS with Jet Stream Technology for Pharmaceuticals and Personal Care Products in Water Application Note Environmental Authors Imma Ferrer, E. Michael
More informationSensitive HPLC Method for Triterpenoid Analysis Using Charged Aerosol Detection with Improved Resolution
Sensitive HPLC Method for Triterpenoid Analysis Using Charged Aerosol Detection with Improved Resolution Marc Plante, Bruce Bailey, Christopher Crafts, Ian N. Acworth Thermo Fisher Scientific, Chelmsford,
More informationColumnsAcclaim PolarAdvantage II (PA2) HPLC Columns
ColumnsAcclaim PolarAdvantage II (PA) HPLC Columns A Unique and Complementary Alternative to Conventional C8.8 Column: Acclaim PA, µm Peaks: ( ppm each) Dimensions:. mm. Maleate Mobile Phase: MeOH/.% NH
More informationAnalysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research
Analysis of Serum 17-Hydroxyprogesterone, Androstenedione, and Cortisol by UPLC-MS/MS for Clinical Research Heather A Brown, 1 Claudia Rossi, 2 and Lisa J Calton 1 1 Waters Corporation, Wilmslow, UK 2
More informationMetoprolol and Select Impurities Analysis Using a Hydrophilic Interaction Chromatography Method with Combined UV and Charged Aerosol Detection
and Select Impurities Analysis Using a ydrophilic Interaction Chromatography Method with Combined UV and Charged Aerosol Detection Bruce Bailey, Ph. D. Thermo Fisher Scientific, Chelmsford, MA, USA Application
More informationQuick Guide QUICK GUIDE. Activity 1: Determine the Reaction Rate in the Presence or Absence of an Enzyme
Activity 1: Determine the Reaction Rate in the Presence or Absence of an 1. Find your 15 ml conical tubes labeled Stop Solution, 1.5 mm Substrate, and Buffer. Write your initials on each tube. 2. Label
More informationDetermination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry
Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry Application Note Doping Control Authors Prof. Maria Kristina Parr Freie Universität Berlin Institute
More informationDeveloping Analytical Chromatographic Methods for Pharmaceutical Stability Investigations
Developing Analytical Chromatographic Methods for Pharmaceutical Stability Investigations Warren B Potts III Senior Director Americas Marketing Warren_potts@waters.com 2017 Waters Corporation 1 Outline
More informationGemini-NX Performance paired with Axia Technology
Si Si Si Si Si Si Si C Si Si Si Si Si Gemini-NX Performance paired with Axia Technology Gemini -NX Axia Packed Technology Improves Yield, Throughput, and Column Lifetime Ideal Purification Platform While
More informationHigh Performance Liquid Chromatography. Table 1: Allowed HPLC Adjustment of USP <621> and EP <2.2.46>
High Performance Liquid Chromatography HPLC-9 Ultra-high Speed Analysis of Ibuprofen within USP Allowed Limits by Nexera Method Scouting In recent years, high-throughput analytical techniques have
More informationCHROMABOND HLB. Introduction. Advantages of CHROMABOND HLB. Technical data
Introduction The enrichment of hydrophilic analytes from polar matrices is a challenge because they often cannot be retained by C 18 / C 8 -modified silica or hydrophobic polymer adsorbents. To overcome
More informationAccelerated Solvent Extraction GC-MS Analysis and Detection of Polycyclic Aromatic Hydrocarbons in Soil
Accelerated Solvent Extraction GC-MS Analysis and Detection of Polycyclic Aromatic Hydrocarbons in Soil Che Jinshui, 1 Deng Guifeng, 1 Liang Lina, 1 and Aaron Kettle, 2 1 Thermo Fisher Scientific (China)
More informationApplicationNOTE A STUDY OF THE ANALYSIS OF POLYBROMINATED DIPHENYL ETHER FLAME RETARDANTS BY GC/MS/MS. Introduction. Materials and Methods
Abstract The development of a GC/MS/MS method for the analysis of brominated flame retardants will be presented. Standard methods require the use of high resolution magnetic sector instrumentation, which
More informationUSP Method Transfer and Routine Use Analysis of Irbesartan Tablets from HPLC to UPLC
USP Method Transfer and Routine Use Analysis of Tablets from HPLC to UPLC Aparna Chavali, Tanya Jenkins and Patricia McConville Waters Corporation, 34 Maple Street, Milford, MA USA APPLICATION BENEFITS
More informationUPLC Method Development and Validation
UPLC Method Development and Validation Rev. 2 2008 Waters Corporation Challenges of Method Development Methods are developed throughout the drug development process Samples vary in complexity Redundancy
More informationYour Reversed Phase Method
PLC Columns for Your Reversed Phase Method Balanced Non-Polar & Polar Selectivity Strong Non-Polar & Polar Selectivity Strong Polar & Aromatic Selectivity Unique Isomeric & alogenated Selectivity Robust
More informationRevision Bulletin Official April 1, 2014 Alprazolam 1
. Apparatus Official April 1, 2014 Alprazolam 1 1: 100 rpm Alprazolam Extended-Release Tablets s: 1, 4, 8, and 12 h Mobile phase: Acetonitrile, tetrahydrofuran, and Medium (7:1:12) DEFINITION Alprazolam
More informationRoutine MS Detection for USP Chromatographic Methods
Daniel S. Root, Thomas E. Wheat, and Patricia McConville Waters Corporation, Milford, MA, USA APPLICATION BENEFITS This approach enables mass spectral analysis of peaks directly from unmodified USP HPLC
More informationRapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies
Rapid, Reliable Metabolite Ratio Evaluation for MIST Assessments in Drug Discovery and Preclinical Studies Jonathan Danaceau, Erin Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA
More informationIDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)
Document A. THIN LAYER CHROMATOGRAPHY (TLC) 1. SCOPE AND FIELD OF APPLICATION The method describes the identification of hydrocortisone acetate, dexamethasone, betamethasone, betamethasone 17-valerate
More informationpenta-hilic UHPLC COLUMNS
penta-hilic UHPLC COLUMNS penta-hilic Highly retentive, proprietary penta-hydroxy-ligand Excellent peak shape for polar compounds with a variety of functional groups: acids, bases, zwitterions strong and
More informationHPLC Determination of Antidepressants and their Metabolites in Plasma
HPLC Determination of Antidepressants and their Metabolites in Plasma
More informationAnalyzing Residual Solvents in Pharmaceutical Products Using GC Headspace with Valve-and-Loop Sampling
Analyzing Residual Solvents in Pharmaceutical Products Using GC Headspace with Valve-and-Loop Sampling Andrea Caruso and Massimo Santoro, Thermo Fisher Scientific, Milan, Italy Application Note 1316 Key
More informationFast methods for the determination of ibuprofen in drug products
APPLICATION NOTE 779 Fast s for the determination of ibuprofen in drug products Authors Sylvia Grosse, Mauro De Pra, Frank Steiner, Thermo Fisher Scientific, Germering, Germany Keywords Pharmaceutical,
More informationStreamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System
Streamlining the Analysis of Oral Contraceptives Using the ACQUITY UPLC H-Class System Margaret Maziarz, Sean M. McCarthy, Michael D. Jones, and Warren B. Potts Waters Corporation, Milford, MA, USA A P
More informationAutomating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents
Automating Method Development with an HPLC System Optimized for Scouting of Columns and Eluents Marco Karsten, Bas, Dolman, Giovanni Maio, Frank Steiner, Holger Franz, Frank Arnold and Remco Swart LC Packings,
More informationEPA Method 1694: Analysis of Pharmaceuticals and Personal Care Products in Water
EPA Method 1694: Analysis of Pharmaceuticals and Personal Care Products in Water UCT Part Numbers ECHLD156-P ENVIRO-CLEAN HL DVB 500 mg, 6 ml cartridge VMF016GL 16 position glass block manifold VMFSTFR12
More information2017 Source of Foreign Income Earned By Fund
2017 Source of Foreign Income Earned By Fund Putnam Emerging Markets Equity Fund EIN: 26-2670607 FYE: 08/31/2017 Statement Pursuant to 1.853-4: The fund is hereby electing to apply code section 853 for
More informationWelcome to our E-Seminar: Choosing HPLC Columns for Faster Analysis Smaller and Faster
Welcome to our E-Sear: Choosing HPLC Columns for Faster Analysis Smaller and Faster High Throughput/Fast LC Requires. Short columns 0 mm or shorter Small particle sizes. µm Rapid Resolution or new.8 µm
More information[ Care and Use Manual ]
high Strength Silica hplc Columns Contents I. INTRODUCTION II. CONECTING THE COLUMN TO THE HPLC SYSTEM III. Waters Small Particle Size (3.5 m) Columns Fast Chromatography IV. Column Equilibration V. Column
More informationUtility of H-SRM to Reduce Matrix Interference in Food Residue Analysis of Pesticides by LC-MS/MS Using the TSQ Quantum Discovery
Application Note: 3 Utility of H-SRM to Reduce Matrix Interference in Food Residue Analysis of Pesticides by LC-MS/MS Using the TSQ Quantum Discovery Yoko Yamagishi, Thermo Fisher Scientific, C-2F 3-9
More informationAPPLICATIONS TN Peptide Purification Method Development: Application for the Purification of Bivalirudin. Introduction
Peptide Purification Method Development: Application for the Purification of Bivalirudin Marc Jacob, Joshua Heng, and Tivadar Farkas Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 91 USA In this technical
More informationIt s hot! ZIC -chilic
It s hot! ZIC -chilic Complementary selectivity for HPLC and LC-MS separation of polar hydrophilic compounds EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany ZIC -chilic Your benefits
More informationNext Generation of Phenyl Columns. Chromatography Products.
Next Generation of Phenyl Columns Chromatography Products RESOLUTION EVOLUTION The Next Generation of Phenyl Column Chemistry The phase is the next generation of phenyl column chemistries, providing both
More informationCHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW
75 CHAPTER 3 DEVELOPMENT AND APPLICATION OF STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF NEVIRAPINE AND ITS IMPURITIES IN COMBINATION DRUG PRODUCT 3.1 INTRODUCTION OF DOSAGE FORM AND LITERATURE
More informationRevision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance
Niacin Extended-Release Tablets Type of Posting Posting Date Official Date Expert Committee Reason for Revision Revision Bulletin 27 Jan 2017 01 Feb 2017 Non-Botanical Dietary Supplements Compliance In
More information[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.
ACQUITY UPLC/QD AALYI F PLYMER ADDITIVE Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U..A. IT RDUCTI Typical polymer additives include light and heat stabilizers, UV absorbers,
More informationQ-TOF PREMIER DYNAMIC RANGE ENHANCEMENT AND ACCURATE MASS MEASUREMENT PERFORMANCE
Q-TOF PREMIER DYAMIC RAGE EHACEMET AD ACCURATE MASS MEASUREMET PERFORMACE Michael McCullagh, Jose Castro-Perez, and Lisa Calton Waters Corporation, Manchester, UK ITRODUCTIO The use of time-of-flight (TOF)
More informationA Study of Stability, Robustness and Time Efficiency of a New HPLC and a New Tandem MS
A Study of Stability, Robustness and Time Efficiency of a New HPLC and a New Tandem MS Jason Lai, Jia Wang, Brad Hart, Pavel Aronov, Kristine Van Natta, Marta Kozak, Jorge Valdivia, Andy Jacobs, Haibo
More informationImproved Extraction of THC and its Metabolites from Oral Fluid Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18
Using Oasis PRiME HLB Solid Phase Extraction (SPE) and a UPLC CORTECS C 18 Column Xin Zhang, Jonathan P. Danaceau, and Erin E. Chambers Waters Corporation, Milford, MA, USA APPLICATION BENEFITS Semi-validated
More informationNew On-Line High-Pressure Electrolytic Eluent Generators for Ion Chromatography
New On-Line High-Pressure Electrolytic Eluent Generators for Ion Chromatography Yan Liu, Zhongqing Lu, and Chris Pohl, Thermo Fisher Scientific, Sunnyvale, CA USA Overview Purpose: In this work, new high-pressure
More informationExtraction of Aflatoxins and Ochratoxin from Dried Chili Using ISOLUTE. Myco Prior to LC-MS/MS Analysis
Application Note AN785 Extraction of Aflatoxins and chratoxin From Dried Chili Using ISLUTE Myco prior to LC-MS/MS Analysis Page Extraction of Aflatoxins and chratoxin from Dried Chili Using ISLUTE Myco
More informationAn Evaluation of Various High-Resolution, Accurate-Mass Scan Modes for In Vitro Drug Discovery Screening
An Evaluation of Various High-Resolution, Accurate-Mass Scan Modes for In Vitro Drug Discovery Screening Jonathan McNally, 1 Nicholas Duczak Jr., 1 Patrick Bennett, 1 Francois Espourteille, and Maciej
More informationpenta-hilic UHPLC COLUMNS
penta-hilic UHPLC COLUMNS Highly retentive, proprietary penta-hydroxy-ligand penta-hilic Excellent peak shape for polar compounds with a variety of functional groups: acids, bases, zwitterions strong and
More informationDEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM
IJPSR (2013), Vol. 4, Issue 2 (Research Article) Received on 28 September, 2012; received in revised form, 24 November, 2012; accepted, 23 January, 2013 DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR
More informationRevision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance
Niacin Extended-Release Tablets Type of Posting Posting Date Official Date Expert Committee Reason for Revision Revision Bulletin 29 Dec 2017 01 Jan 2018 Non-Botanical Dietary Supplements Compliance In
More informationFrank Steiner, Michael Heidorn, and Markus M. Martin Thermo Fisher Scientific, Germering, Germany
Generic Method Approach for Pharmaceutical Drug Discovery and Development using Reversed-Phase Hydrophilic Interaction Liquid Chromatography with Universal Charged Aerosol Detection Frank Steiner, Michael
More informationAppendix B: Detailed tables showing overall figures by country and measure
44 country and measure % who report that they are very happy Source: World Values Survey, 2010-2014 except United States, Pew Research Center 2012 Gender and Generations survey and Argentina 32% 32% 36%
More informationThermo Scientific Accucore XL HPLC Columns. Technical Manual
Thermo Scientific Accucore XL HPLC Columns Technical Manual Thermo Scientific Accucore XL HPLC Columns Based on Core Enhanced Technology using µm solid core particles, Accucore XL HPLC columns allow users
More informationKey Words Q Exactive, Accela, MetQuest, Mass Frontier, Drug Discovery
Metabolite Stability Screening and Hotspot Metabolite Identification by Combining High-Resolution, Accurate-Mass Nonselective and Selective Fragmentation Tim Stratton, Caroline Ding, Yingying Huang, Dan
More informationRapid Quan/Qual Metabolic Stability Analysis with Online Oxidative Metabolism Synthesis
Rapid Quan/Qual Metabolic Stability Analysis with Online Oxidative Metabolism Synthesis Tim Stratton 1, Yingying Huang 1, Katianna Pihakari 1, Ian Acworth 2, and Michael Weber 2 1 Thermo Fisher Scientific,
More informationThe Secrets of Rapid HPLC Method Development. Choosing Columns for Rapid Method Development and Short Analysis Times
The Secrets of Rapid HPLC Method Development Choosing Columns for Rapid Method Development and Short Analysis Times Rapid Analysis Is More Than Run Time It is developing a method to meet a goal and developing
More informationEliminating Unwanted Variability in LC Methods: More Uptime, More Sample Throughput
Eliminating Unwanted Variability in LC Methods: More Uptime, More Sample Throughput HPLC Separation Robustness and Ruggedness Group/Presentation Title June 20, Agilent 2017Month Restricted ##, 200X Page
More informationConc n of A OAs present (um) Conc n of B OAs present (um)
Materials and Instrumentation: Acquity UPLC BEH C18 2.1 x 100 mm, 1.7 µm column, Waters Corporation, Cat. No. 186002352 O-Benzylhydroxylamine, Sigma-Aldrich Cat. No. B22984 N-(3-Dimethylaminopropyl)-N
More informationNUCLEOSHELL core-shell silica for HPLC
NUCLESHELL core-shell silica for HPLC Core-shell technology µm 0. µm.8 µm 0. µm.7 µm 0. µm.7 µm 0. µm Key feature Solid core of silicon dioxide, homogeneous shell of porous silica Highest efficiency compared
More information